Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT01336101

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01336101
  • WHO UTN U1111-1121-6816
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01336101. Allocation not applicable; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent
Acronym
SUMMIT
Condition
Peripheral Arterial Diseases
Condition
Superficial Femoral Artery Stenosis
Intervention (Device)
EPIC™ Self-Expanding Nitinol Vascular Stent
Lead sponsor
Provascular GmbH (class: other)
Collaborator
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct01336101
Content hash
ea031f1d2e0561060ce1a9f63a345d81222fa70d986e6ee0b99a830b5964da43